Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Respiração e Dinâmica em Tempo Real no Movimento Paradoxal das Pregas Vocais Induzido pelo Exercício (EILO)

4 de novembro de 2026 atualizado por: Rita R. Patel, Indiana University

Dinâmica Respiratória e em Tempo Real no Movimento Paradoxal das Pregas Vocais Induzido pelo Exercício

The overall objectives of the proposed research are to:

  1. Evaluate the diagnostic validity of a novel mechano-acoustic signatures of task-characteristic activity during symptomatic and asymptomatic breathing in Exercise-Induced Laryngeal Obstruction (EILO) patients with the use of a novel miniature, soft wearable skin-mounted device,
  2. Identify the mechanism/s of paradoxical respiratory control in EILO by quantifying the relationship between pulmonary mechanics, partial pressure of carbon dioxide (PCO2) maintenance, and vocal fold aperture prior to and during symptomatic and asymptomatic exercise ventilation, and
  3. Identify unique biophysiological factors contributing to EILO among exercisers with and without EILO. Findings will be highly novel and clinically significant for early identification and management of EILO.

The main study will enroll 60 participants with EILO and 60 without EILO to complete three separate visits:

  1. Exercise treadmill study
  2. Free running with the device on the neck
  3. Undergoing MRI (Magnetic Resonance Imaging) of the vocal tract.

Visão geral do estudo

Descrição detalhada

Main Study

At the first study visit, participants will sign informed consent, complete study questionnaires, have their height, weight, and body composition measured, and perform resting pulmonary function tests. Participants will then warm up on the treadmill for 10 minutes. An endoscope will be placed in one nostril until the vocal folds are visible, and subjects will be fitted with a chest strap heart rate monitor, an oro-nasal face mask, and the mechanoacoustic device. This sensor is placed on the neck with a velcro band. Participants will then undergo a graded exercise test during which a carbon-dioxide enriched gas mixture will be administered. The amount of the gas mixture will be titrated based on measures of the participant's breathing and lung function. This visit will be video recorded.

At the second study visit, participants will be asked to again wear the mechanoacoustic device while free running for 10 minutes in a large room or on a track. This visit will be video-recorded.

At the third study visit, participants will be asked to undergo an MRI scan, during which they will perform a variety of breathing exercises including rest breathing, rapid breathing, pursed lip breathing, sniff, and open mouth breathing. Research personnel will instruct participants in the various breathing techniques prior to the scan.

The study visits may occur in any order.

Tipo de estudo

Intervencional

Inscrição (Estimado)

120

Estágio

  • Fase 2

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

  • Nome: Rita R Patel
  • Número de telefone: 812-855-3886
  • E-mail: patelrir@iu.edu

Locais de estudo

    • Indiana
      • Bloomington, Indiana, Estados Unidos, 47401
        • Recrutamento
        • Indiana University
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 26 anos (Adulto)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria for Exercise-Induced Laryngeal Obstruction (EILO):

  • Physically active >2.5 hours per week
  • Patients with EILO, as diagnosed by routine clinical examination by physician and/or speech language pathologist
  • Age range of 18-26 years
  • Greater difficulty breathing inside compared to out and difficulty breathing which is exacerbated at peak exercise and stops 1-5 minutes after exercise
  • Score of 7 or higher on the Dyspnea Index, which is a validated instrument to capture participant self-report of upper airway dyspnea symptoms.
  • Classified as low risk, based on the modified Physical Activity Readiness Questionnaire (PAR-Q) questionnaire, body mass index, and non-smoking status
  • Negative history of voice disorders, self-report of cognitive difficulties, asthma or other lung disease, cardiac disease, serious orthopedic injuries, current uncontrolled hypertension, illicit drug use, seizure/epilepsy, claustrophobia, use of beta blockers.
  • No metallic, mechanical or magnetic implants such as cardiac devices, cochlear, or other non-removable ear implants, any prosthesis, stents, deep brain stimulator, etc.

Inclusion Criteria for Controls

  • Physically active >2.5 hours per week
  • Age range of 18-26 years
  • Classified as low risk, based on the modified PAR-Q questionnaire, body mass index, and non-smoking status
  • Negative history of voice disorders, self-report of cognitive difficulties, asthma or other lung disease, cardiac disease, serious orthopedic injuries, current uncontrolled hypertension, illicit drug use, seizure/epilepsy, claustrophobia, use of beta blockers.
  • No metallic, mechanical or magnetic implants such as cardiac devices, cochlear, or other non-removable ear implants, any prosthesis, stents, deep brain stimulator, etc.

Exclusion Criteria for EILO:

  • Individuals older than 26 years and younger than 18 years of age.
  • Women who are pregnant or could possibly be pregnant.
  • A 'yes' answer to any of the 14 questions on the PAR-Q pre-participation questionnaire
  • Current smoker
  • Positive history of voice disorders, self-report of cognitive difficulties, asthma or other lung disease, cardiac disease, serious orthopedic injuries, current uncontrolled hypertension, illicit drug use, seizure/epilepsy, claustrophobia, use of beta blockers.
  • Presence of metallic, mechanical or magnetic implants such as cardiac devices, cochlear, or other non-removable ear implants, any prosthesis, stents, deep brain stimulator, etc.
  • Do not report the following: Greater difficulty breathing inside compared to out and difficulty breathing which is exacerbated at peak exercise and stops 1-5 minutes after exercise

Exclusion Criteria for Controls

  • Individuals older than 26 years and younger than 18 years of age.
  • Women who are pregnant or could possibly be pregnant.
  • A 'yes' answer to any of the 14 questions on the PAR-Q pre-participation questionnaire
  • Current smoker
  • Positive history of voice disorders, self-report of cognitive difficulties, asthma or other lung disease, cardiac disease, serious orthopedic injuries, current uncontrolled hypertension, illicit drug use, seizure/epilepsy, claustrophobia, use of beta blockers.
  • Presence of metallic, mechanical or magnetic implants such as cardiac devices, cochlear, or other non-removable ear implants, any prosthesis, stents, deep brain stimulator, etc.
  • Significant acute or chronic medical, neurologic, or illness in the patient that, in the judgment of the Principal Investigator, could compromise subject safety, limit the ability to complete the study, and/or compromise the objectives of the study

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Outro
  • Alocação: Não randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Comparador Ativo: EILO Participants

Breathing Hypercapnic Gas (10% CO2 (carbon dioxide) and 21%O2 (oxygen), balance N210% (nitrogen))

A custom developed mechanoacoustic sensor will be worn on the neck using a Velcro strap. The device will collect audio recordings of breathing and breath sounds and will collect muscle activity from the neck muscles.

Comparador Ativo: Control Participants

Participants without Exercise-induced laryngeal obstruction (EILO).

Breathing Hypercapnic Gas (10% CO2 (carbon dioxide) and 21%O2 (oxygen), balance N210% (nitrogen))

A custom developed mechanoacoustic sensor will be worn on the neck using a Velcro strap. The device will collect audio recordings of breathing and breath sounds and will collect muscle activity from the neck muscles.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Device measurements from real time running
Prazo: Baseline and Periprocedural

Muscle activation of cricothyroid/sternohyoid muscle measured via customized surface electromyography amplifier

Baseline and Periprocedural
Device measurements from real time running
Prazo: Baseline and Periprocedural

Normalized amplitude (100% of maximum voluntary contraction) Burst duration (milliseconds) prior to and during Exercise-Induced Laryngeal Obstruction event of laryngeal closure.

Baseline and Periprocedural
Device measurements from real time running
Prazo: Baseline and Perioprocedural

Exercise-Induced Laryngeal Obstruction signature detected via ultra-low noise micro-electromechanical (MEMS) microphone amplitude (dB) prior to and during EILO. EILO signature detected via accelerometer (g, where g represents the gravitational acceleration of 9.8 m/s2) prior to and during EILO

Baseline and Perioprocedural
Treadmill testing
Prazo: Baseline and Perioprocedural

Breathing frequency (breaths per minute)

Baseline and Perioprocedural
Treadmill testing
Prazo: Baseline

Tidal volume (Liters)

Baseline
Treadmill testing
Prazo: Breath-by-breath baseline and Perioprocedural

Ventilation (Liters/minute)

Breath-by-breath baseline and Perioprocedural
Treadmill testing
Prazo: Baseline and Periprocedural

Partial pressure of arterial carbon dioxide estimated from end-tidal partial pressure of carbon dioxide; PetCO2) (mmHg)

Baseline and Periprocedural
MRI Upper Airway Size
Prazo: Baseline

Length (mm), width (mm), and cross-sectional area (mm2) of oropharynx, supraglottis, glottis, immediate subglottis.

Baseline
Upper Airway Aerodynamics
Prazo: Baseline and Periprocedural

pressure (Pa) across oropharynx, supraglottis, and subglottis

Baseline and Periprocedural
Upper Airway Aerodynamics
Prazo: Baseline and Periprocedural

volume flow rate (l/s) across oropharynx, supraglottis, and subglottis

Baseline and Periprocedural
Upper Airway Aerodynamics
Prazo: Baseline and Periprocedural

flow velocities (m/s) across oropharynx, supraglottis, and subglottis

Baseline and Periprocedural

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Self-rating of dyspnea
Prazo: Baseline

Participants will rate breathing intensity and breathing unpleasantness on a Visual Analog Scale of 0 to 100mm, where 0 indicates not at all and 100 indicates maximal imaginable intensity/unpleasantness.

Baseline
Profile of Mood States (POMS)
Prazo: Baseline

The POMS will be used to evaluate the participants' mood and to better understand how the emotional state relates to physical responses during testing. The POMS measures different aspects of mood on a 5-point Likert scale from 0 (not at all) to 4 (extremely).

Baseline
Menstrual Screening Questionnaire
Prazo: Baseline

Female participants will complete a screening questionnaire about menstruation history and use of hormonal birth control which will be used to evaluate the relationship between EILO and menstruation.

Baseline
Pittsburgh Sleep Quality Index (PSQI)
Prazo: Baseline

The PSQI will be used to evaluate the relationship between sleep and exercise. Total PSQI scores range from 0 to 21 with lower scores indicating better sleep quality.

Baseline
International Physical Activity Questionnaire (IPAQ)
Prazo: Baseline

Participants will complete the IPAQ which collects information on the frequency and duration of physical activities.

Baseline

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Investigador principal: Rita Patel, Indiana University

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

12 de agosto de 2026

Conclusão Primária (Estimado)

20 de janeiro de 2032

Conclusão do estudo (Estimado)

20 de janeiro de 2032

Datas de inscrição no estudo

Enviado pela primeira vez

13 de janeiro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

11 de fevereiro de 2026

Primeira postagem (Real)

19 de fevereiro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

9 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

4 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

SIM

Descrição do plano IPD

The data will be available indefinitely, as per NIH's Data Management and Sharing Policy to maximize the appropriate sharing of scientific data.

Tipo de informação de suporte de compartilhamento de IPD

  • PROTOCOLO DE ESTUDO
  • SEIVA
  • ANALYTIC_CODE
  • CSR

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Sim

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Sim

produto fabricado e exportado dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever